548 filings
Page 3 of 28
SC14D9C
b8avkv73axqhhv
1 Nov 22
Written communication relating to third party tender offer
9:27pm
SC TO-C
rse no696t1fkhooh
1 Nov 22
Information about tender offer
5:25pm
8-K
rwi6c
1 Nov 22
Abiomed Announces Second Quarter Revenue of $266 Million, Up 11% In Constant Currency*, Up 7% on a Reported Basis Year Over Year
8:14am
SC14D9C
84zqo no6wmpey2o8g9q
1 Nov 22
Written communication relating to third party tender offer
7:40am
8-K
htw4elnlepxsglmiv
1 Nov 22
Johnson & Johnson to Acquire Abiomed
7:39am
8-K
e8jx3mp4nvmei0 zzomg
12 Aug 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
aw9889hxq
4 Aug 22
Results of Operations and Financial Condition
7:14am
DEFA14A
osqh5 c6cbe573j0
28 Jun 22
Additional proxy soliciting materials
4:32pm
8-K
oguln oyli0e6
21 Jun 22
Other Events
7:12am
SD
q865ffji0jsrf
20 May 22
Conflict minerals disclosure
4:10pm
8-K
i3ve kjerfzu1r83jx
28 Apr 22
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, Up 12% Year Over Year
7:30am
8-K
u069xnt
1 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
opve0ni1efxu500
3 Feb 22
Abiomed Announces Record Revenue of $261 Million, Up 13% Year Over Year
7:19am
8-K
pombxk
28 Oct 21
Abiomed Announces Q2 Fy 2022 Revenue of $248 Million, Up 18% Year Over Year
7:26am
8-K
h11v6eu9
13 Aug 21
Entry into a Material Definitive Agreement
4:01pm